MarketPulse
N

$NAMS

3 articles found
1 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Newamsterdam Pharma Company N.V.

NewAmsterdam Pharma Gears Up for Major Healthcare Conferences Amid CETP Drug Approvals

NewAmsterdam Pharma to present at major June 2026 investor conferences ahead of expected EMA, UK, and Swiss regulatory decisions on cardiovascular drug obicetrapib.
NAMSNAMSWPhase 3 trialsinvestor conference
GlobeNewswire Inc.GlobeNewswire Inc.··Na

NewAmsterdam Pharma Grants $1.4M in Stock Incentives to Five New Employees

NewAmsterdam Pharma approved inducement grants totaling 50,400 options and 15,400 RSUs to five new non-executive employees under Nasdaq compliance rules.
NAMSNAMSWrestricted stock unitsvesting schedule
GlobeNewswire Inc.GlobeNewswire Inc.··Newamsterdam Pharma Company N.V.

NewAmsterdam Pharma Awards Inducement Grants to New Hires Under Nasdaq Rules

NewAmsterdam Pharma grants 15,000 options and 3,200 RSUs to two new executives, complying with Nasdaq listing regulations.
NAMSNAMSWrestricted stock unitsvesting schedule